Abstract
Group A Streptococcus (GAS) is a major cause of both mucosal and invasive human infections. Epithelial and leukocyte production of cationic antimicrobial peptides (AMPs) is an important aspect of mammalian innate immune defense against bacterial infection. In this study, we identify a specific GAS phenotype that confers resistance to host AMPs. Inactivation of the dltA gene in an invasive serotype M1 GAS isolate led to loss of teichoic acid d-alanylation. Compared to the wild-type strain, the GAS dltA mutant was found to be more susceptible to AMP and lysozyme killing. Killing of the dltA mutant by human PMN, which produce AMPs in large amounts, was greatly accelerated. Thus, teichoic acid d-alanylation may contribute to the ability of invasive GAS to bypass mucosal defenses and produce systemic infection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
